Photocoagulation for ROP is gaining in popularity following the advent of indirect ophthalmoscopic delivery systems. Studies comparing laser and cryoablation in the treatment of ROP have found equal efficacy between these two modalities, with fewer complications reported with laser treatment. [5] [6] [7] [8] [9] The outcome and clinical course of 66 consecutive infants (125 eyes) treated for ROP using cryotherapy and laser photocoagulation is described here.
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Patients and methods

Results
Sixty six infants with ROP were treated in this retrospective study. Cryotherapy was the mainstay of treatment from 1989 to mid 1992. Laser photocoagulation has been used from February 1992 to the present day. We compared the demographics of the two treatment groups, looking specifically at surgical results with anterior and posterior ROP ( The improvement in our results may be attributed to the change in treatment modality, an increasing experience effect, and finally to We now treat zone I disease as soon as plus disease develops. Stemnberg and Tasman comment that waiting until threshold disease develops in zone I leads to a high failure rate.'2 13 Fleming et al treated 18 eyes in nine infants with posterior ROP who were prethreshold with signs of plus disease.14 Disease regressed in 17 of the 18 eyes. In our study two of the eight infants with posterior disease were treated prethreshold with the diode laser, resulting in successful outcomes. Treatment of posterior disease with laser, especially zone I, was considerably easier technically and, we felt, allowed for a more complete treatment. A combination of all these factors -that is, treatment technically easier to administer, some eyes treated prethreshold, a more complete treatment, and experience gained over 6 years contributed to the improved results in this subgroup of infants with ROP. We noted that there was a significant difference between the number of eyes with posterior disease, between the group treated with cryotherapy (April 1989-June 1992), and the laser treated infants (February 1992 -January 1995 . We speculate that changes in the management of preterm labour and postnatal care may have contributed to this.
Six infants with anterior disease were treated prethreshold with argon laser. Three of these infants had asymmetric disease, having reached threshold disease in the fellow eye. The treatment administered in these eyes was localised to the avascular retina anterior to the area of stage 3 involvement. None of these eyes progressed to threshold, or had an unfavourable outcome. The infants with bilateral prethreshold anterior disease, had 3 to 4 clock hours of stage 3 ROP, where fibrovascular tissue had advanced a significant distance into the vitreous. Because of the risk of macular ectopia in these isolated cases, a decision to treat prethreshold was made.
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